Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.20
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.20). Revenue for the quarter came in at $166.45 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
